PL2283113T3 - Pluripotencjalne komórki - Google Patents

Pluripotencjalne komórki

Info

Publication number
PL2283113T3
PL2283113T3 PL09734026T PL09734026T PL2283113T3 PL 2283113 T3 PL2283113 T3 PL 2283113T3 PL 09734026 T PL09734026 T PL 09734026T PL 09734026 T PL09734026 T PL 09734026T PL 2283113 T3 PL2283113 T3 PL 2283113T3
Authority
PL
Poland
Prior art keywords
pluripotent cells
pluripotent
cells
Prior art date
Application number
PL09734026T
Other languages
English (en)
Polish (pl)
Inventor
Alireza Rezania
Original Assignee
Janssen Biotech, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech, Inc filed Critical Janssen Biotech, Inc
Publication of PL2283113T3 publication Critical patent/PL2283113T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09734026T 2008-04-24 2009-04-22 Pluripotencjalne komórki PL2283113T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/108,872 US7939322B2 (en) 2008-04-24 2008-04-24 Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm

Publications (1)

Publication Number Publication Date
PL2283113T3 true PL2283113T3 (pl) 2017-09-29

Family

ID=41129142

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09734026T PL2283113T3 (pl) 2008-04-24 2009-04-22 Pluripotencjalne komórki
PL13163321T PL2669366T3 (pl) 2008-04-24 2009-04-22 Pluripotencjalne Komórki

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13163321T PL2669366T3 (pl) 2008-04-24 2009-04-22 Pluripotencjalne Komórki

Country Status (14)

Country Link
US (2) US7939322B2 (cg-RX-API-DMAC7.html)
EP (3) EP2669366B1 (cg-RX-API-DMAC7.html)
JP (1) JP5763524B2 (cg-RX-API-DMAC7.html)
KR (3) KR101690773B1 (cg-RX-API-DMAC7.html)
CN (1) CN102083965B (cg-RX-API-DMAC7.html)
AU (1) AU2009239442B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0911599A2 (cg-RX-API-DMAC7.html)
CA (2) CA2948488A1 (cg-RX-API-DMAC7.html)
ES (2) ES2633455T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010011739A (cg-RX-API-DMAC7.html)
PL (2) PL2283113T3 (cg-RX-API-DMAC7.html)
RU (1) RU2553538C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009132063A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201008391B (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090203141A1 (en) * 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
EP2185693B1 (en) 2007-07-31 2019-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
CN107574142B (zh) 2007-11-27 2021-07-06 生命扫描有限公司 人胚胎干细胞的分化
RU2551772C2 (ru) 2008-02-21 2015-05-27 Сентокор Орто Байотек Инк. Способы, поверхностно-модифицированные носители и композиции для иммобилизации, культивирования и открепления клеток
KR20180018839A (ko) 2008-06-30 2018-02-21 얀센 바이오테크 인코포레이티드 만능 줄기 세포의 분화
CN102272291B (zh) 2008-10-31 2018-01-16 詹森生物科技公司 人胚胎干细胞向胰腺内分泌谱系的分化
CA2742267C (en) 2008-10-31 2019-06-04 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
EP3260534A1 (en) 2008-11-20 2017-12-27 Janssen Biotech, Inc. Pluripotent stem cell culture on micro-carriers
PL2366022T3 (pl) 2008-11-20 2016-11-30 Sposoby i kompozycje do przyłączania i hodowli komórek na podłożach planarnych
JP6219568B2 (ja) 2009-07-20 2017-10-25 ヤンセン バイオテツク，インコーポレーテツド ヒト胚性幹細胞の分化
KR101867369B1 (ko) 2009-12-23 2018-06-14 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
PH12012501254A1 (en) * 2009-12-23 2012-11-05 Janssen Biotech Inc Differentiation of human embryonic stem cells
CA2791476C (en) 2010-03-01 2020-06-30 Janssen Biotech, Inc. Methods for purifying cells derived from pluripotent stem cells
AU2011250912A1 (en) 2010-05-12 2012-11-22 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
RU2620938C2 (ru) 2010-08-31 2017-05-30 Янссен Байотек, Инк. Дифференцирование эмбриональных стволовых клеток человека
KR101836855B1 (ko) 2010-08-31 2018-04-19 얀센 바이오테크 인코포레이티드 만능 줄기 세포의 분화
ES2659393T3 (es) 2010-08-31 2018-03-15 Janssen Biotech, Inc. Diferenciación de células madre embrionarias humanas
JP6312591B2 (ja) 2011-06-21 2018-04-18 ノヴォ ノルディスク アー／エス 多能性幹細胞からの胚体内胚葉の効率的な誘導
SG11201403473QA (en) 2011-12-22 2014-10-30 Janssen Biotech Inc Differentiation of human embryonic stem cells into single hormonal insulin positive cells
EA034065B1 (ru) * 2012-02-14 2019-12-24 Вашингтон Стейт Юниверсити Способ культивирования бычьих и свиных сперматогониальных стволовых клеток без использования клеток-фидеров
US10106773B2 (en) * 2012-03-01 2018-10-23 University Of Miami Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues
HK1206058A1 (en) * 2012-03-07 2015-12-31 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
WO2013151186A1 (ja) * 2012-04-06 2013-10-10 国立大学法人京都大学 エリスロポエチン産生細胞の誘導方法
AR090970A1 (es) * 2012-05-07 2014-12-17 Janssen Biotech Inc Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico
US10066210B2 (en) 2012-06-08 2018-09-04 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201408150UA (en) * 2012-06-14 2015-01-29 Janssen Biotech Inc Treatment of pluripotent cells
GB2504996A (en) * 2012-08-17 2014-02-19 Univ Keele Embryonic stem cell culture method
WO2014033322A1 (en) 2012-09-03 2014-03-06 Novo Nordisk A/S Generation of pancreatic endoderm from pluripotent stem cells using small molecules
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
RU2018116647A (ru) 2012-12-31 2018-10-24 Янссен Байотек, Инк. Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки
CA2896750A1 (en) 2012-12-31 2014-07-03 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
KR101942769B1 (ko) 2012-12-31 2019-01-28 얀센 바이오테크 인코포레이티드 Hb9 조절제를 사용하는 인간 배아 줄기세포의 췌장 내분비 세포로의 분화
US10266807B2 (en) * 2013-04-03 2019-04-23 FUJIFILM Cellular Dynamics, Inc. Methods and compositions for culturing endoderm progenitor cells in suspension
GB201317869D0 (en) * 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
CN117821369A (zh) 2014-05-16 2024-04-05 詹森生物科技公司 小分子增强胰腺内分泌细胞中的mafa表达的用途
EP3286300B1 (en) 2015-04-24 2020-10-21 University of Copenhagen Isolation of bona fide pancreatic progenitor cells
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
NL2017670B1 (en) * 2016-10-25 2018-05-04 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Molecular indicators for predicting response to hormonal therapy in breast cancer
WO2018089011A1 (en) 2016-11-10 2018-05-17 Viacyte, Inc Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
EP3655774B1 (en) * 2017-07-17 2024-09-25 Miltenyi Biotec B.V. & Co. KG A method for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells
CA2983845C (en) 2017-10-26 2024-01-30 University Of Copenhagen Generation of glucose-responsive beta cells
US12378572B2 (en) 2018-09-07 2025-08-05 Crispr Therapeutics Ag Universal donor cells
AU2020283056B2 (en) 2019-05-31 2023-06-08 Viacyte, Inc. A biocompatible membrane composite
CN114401752B (zh) 2019-05-31 2023-04-04 W.L.戈尔及同仁股份有限公司 具有受控氧扩散距离的细胞封装装置
WO2020243663A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
US20220233298A1 (en) 2019-05-31 2022-07-28 W. L. Gore & Associates, Inc. A biocompatible membrane composite
KR20220052370A (ko) 2019-09-05 2022-04-27 크리스퍼 테라퓨틱스 아게 보편적 공여자 세포
US11116798B2 (en) 2019-09-05 2021-09-14 Crispr Therapeutics Ag Universal donor cells
AU2021414617A1 (en) 2020-12-31 2023-08-10 Crispr Therapeutics Ag Universal donor cells

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583308A (en) * 1897-05-25 m miehle
US5834308A (en) 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
WO1999020741A1 (en) 1997-10-23 1999-04-29 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6610540B1 (en) * 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
CA2359159A1 (en) * 1999-01-21 2000-07-27 Vitro Diagnostics, Inc. Immortalized cell lines and methods of making the same
US20030082155A1 (en) * 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
AU778155B2 (en) * 1999-12-13 2004-11-18 Scripps Research Institute, The Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7432104B2 (en) * 2001-08-06 2008-10-07 Bresgen Inc. Methods for the culture of human embryonic stem cells on human feeder cells
JP4666567B2 (ja) * 2001-12-07 2011-04-06 ジェロン・コーポレーション ヒト胚幹細胞由来の膵島細胞
US20060003446A1 (en) 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
US20060122104A1 (en) 2002-05-28 2006-06-08 Presnell Sharon C Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
US6877147B2 (en) * 2002-07-22 2005-04-05 Broadcom Corporation Technique to assess timing delay by use of layout quality analyzer comparison
US20040110287A1 (en) 2002-07-29 2004-06-10 Es Cell International Pte Ltd. Multi-step method for the differentiation of insulin positive, glucose responsive cells
WO2004090110A2 (en) 2003-03-31 2004-10-21 Bresagen Inc. Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
ITRM20030395A1 (it) 2003-08-12 2005-02-13 Istituto Naz Per Le Malattie Infettive Lazz Terreno di coltura per il mantenimento, la proliferazione e il differenziamento di cellule di mammifero.
WO2005063971A2 (en) * 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm
US20050266554A1 (en) * 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
WO2005065354A2 (en) 2003-12-31 2005-07-21 The Burnham Institute Defined media for pluripotent stem cell culture
US20090155218A1 (en) 2004-03-10 2009-06-18 Alberto Hayek Compositions and methods for growth of embryonic stem cells
CN103103158B (zh) 2004-04-27 2016-08-03 韦尔赛特公司 细胞培养基
CN102925406B (zh) 2004-07-09 2019-11-22 维亚希特公司 鉴定用于分化定型内胚层的因子的方法
KR20070083559A (ko) 2004-08-13 2007-08-24 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 인간 배아 줄기세포에서의 자가재생 및 분화를 위한 조성물및 방법
SG160373A1 (en) 2005-03-04 2010-04-29 John Oaeneil Adult pancreatic derived stromal cells
WO2007027156A1 (en) 2005-09-02 2007-03-08 Agency For Science, Technology And Research Method of deriving mesenchymal stem cells
WO2007030870A1 (en) 2005-09-12 2007-03-22 Es Cell International Pte Ltd Cardiomyocyte production
WO2007082963A1 (es) 2006-01-18 2007-07-26 Fundación Instituto Valenciano De Infertilidad Líneas de células madre embrionarias humanas y métodos para usar las mismas
DK2650360T3 (da) 2006-03-02 2019-10-07 Viacyte Inc Endokrine prekursorceller, pancreatiske hormon udtrykkende celler og fremgangsmåder til fremstilling
GB2452186B (en) * 2006-05-02 2011-01-26 Wisconsin Alumni Res Found Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
US7964402B2 (en) 2006-05-25 2011-06-21 Sanford-Burnham Medical Research Institute Methods for culture and production of single cell populations of human embryonic stem cells
US20080003676A1 (en) 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
JP5738591B2 (ja) 2007-07-18 2015-06-24 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． ヒト胚幹細胞の分化
EP2185693B1 (en) * 2007-07-31 2019-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
US8623648B2 (en) * 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells

Also Published As

Publication number Publication date
KR102057056B1 (ko) 2019-12-18
EP2669366B1 (en) 2018-01-31
JP2011518562A (ja) 2011-06-30
KR20100134127A (ko) 2010-12-22
AU2009239442A1 (en) 2009-10-29
ZA201008391B (en) 2014-04-30
JP5763524B2 (ja) 2015-08-12
MX2010011739A (es) 2010-11-22
KR20160150656A (ko) 2016-12-30
US20090269845A1 (en) 2009-10-29
EP3327114B1 (en) 2019-11-06
PL2669366T3 (pl) 2018-06-29
EP2283113B1 (en) 2017-05-17
CA2722619C (en) 2016-12-20
EP2283113A2 (en) 2011-02-16
AU2009239442B2 (en) 2015-06-11
ES2633455T3 (es) 2017-09-21
KR101832902B1 (ko) 2018-02-27
EP2669366A3 (en) 2014-03-05
ES2663421T3 (es) 2018-04-12
WO2009132063A2 (en) 2009-10-29
RU2010147817A (ru) 2012-05-27
CA2722619A1 (en) 2009-10-29
WO2009132063A3 (en) 2010-03-18
CA2948488A1 (en) 2009-10-29
EP3327114A1 (en) 2018-05-30
KR20180021250A (ko) 2018-02-28
CN102083965A (zh) 2011-06-01
US7939322B2 (en) 2011-05-10
BRPI0911599A2 (pt) 2020-08-18
KR101690773B1 (ko) 2016-12-28
USRE43876E1 (en) 2012-12-25
EP2669366A2 (en) 2013-12-04
RU2553538C2 (ru) 2015-06-20
CN102083965B (zh) 2014-10-15

Similar Documents

Publication Publication Date Title
ZA201008391B (en) Pluripotent cells
IL212471A0 (en) Cell transplantation
IL216624A0 (en) Fucosylation-deficient cells
GB0908613D0 (en) T Cell Reseptors
SG10201500674YA (en) Pluripotent stem cells
GB0806216D0 (en) Interconnector
GB0813669D0 (en) Electrolyte
GB0904263D0 (en) Electrolyte composition
GB0800524D0 (en) Cell culture system
GB0920775D0 (en) Cells
GB0817990D0 (en) Cell culture vessel
ZA201202939B (en) Whole cell biocatalyst
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
GB201012650D0 (en) Bioreactor
GB0808778D0 (en) Cell culture technique
GB0810505D0 (en) M cell
GB0811353D0 (en) Cell line
GB0908223D0 (en) Cells
GB0901675D0 (en) Cells
HUE052153T2 (hu) Fukoziláció-deficiens sejtek
GB0920035D0 (en) Cell
GB0922428D0 (en) Cell culture
GB0915268D0 (en) Cell culture
IL244553B (en) Altered placental cells
GB0812757D0 (en) Cell profliferation standards